Bone marrow transplantation for Hodgkin's disease and lymphoma

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


The treatment of patients with high-dose chemotherapy and autologous transplantation for recurrent or high-risk lymphomas has greatly expanded over the past few years. With the use of new supportive care measures such as newer antibiotics and hematopoietic growth factors, the morbidity and mortality rate associated with this therapy have diminished. This in turn has allowed successful use of the therapy earlier in the disease course, with resultant increases in disease-free survival rates. Future trials will strive to utilize new therapies and supportive care measures to improve on the results even further.

Original languageEnglish (US)
Pages (from-to)255-263
Number of pages9
JournalAnnual Review of Medicine
StatePublished - 1993


  • chemotherapy
  • hematopoietic growth factors
  • non-Hodgkin's lymphoma

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Bone marrow transplantation for Hodgkin's disease and lymphoma'. Together they form a unique fingerprint.

Cite this